BREAKING
Kolkata Ring Road Project 75% Complete, Fast-Track Link Opens Ahead of Schedule|Kolkata Metro Green Line: Commercial Services to Howrah Maidan Commence with Record Turnout|East Bengal vs Mohun Bagan: High-Voltage Kolkata Derby Scheduled for This Weekend at Salt Lake Stadium|Durga Puja 2026: North & South Kolkata Pandals Unveil Eco-Friendly Thematic Showcases|New Town Tech Corridor: Global IT Giants Announce 5,000+ New Job Openings This Quarter|Weather Alert: Pleasant Evening Breeze Forecast Across South Bengal and City Coast|Netaji Subhash Chandra Bose Airport Expands Contactless DigiYatra Terminal 2 Gates|Heritage Revival: Historic Tramway Line Recommissioning Approved by Transport Department|KMC Launches 24/7 Digital Citizen Portal for Instant Municipal Grievance Resolution|Hilsa Fish Supplies Surge in City Wholesale Markets, Bringing Relief to Consumers|Smart City Mission: Kolkata Ranks Among Top Urban Digital Centers Nationwide|Fire Safety Audit: Comprehensive Inspections Initiated Across Central Kolkata Markets|
Our Kolkata
HealthLIVE UPDATEVerified by OurKolkata Newsroom

Kerala Health Minister Calls for Probe into Expired Drugs Used on Nipah Patients

Kerala Health Minister K. Muraleedharan has announced that a medical board will investigate whether expired Remdesivir was administered to patients suffering from the Nipah virus, potentially contributing to several deaths. The inquiry follows concerns over drug expiry dates and patient safety, prompting the state to review its pharmaceutical protocols.

Kerala Health Minister Calls for Probe into Expired Drugs Used on Nipah Patients
Kerala Health Minister Calls for Probe into Expired Drugs Used on Nipah PatientsPhoto via The Hindu — National

Overview

In the state of Kerala, Health Minister K. Muraleedharan has publicly requested a formal investigation into the use of expired Remdesivir on patients who contracted the Nipah virus. The inquiry comes after reports of multiple fatalities among Nipah patients, raising questions about drug quality and oversight.

Key Developments

  • The allegation centers on the administration of Remdesivir that had surpassed its expiry date to patients treated for Nipah virus infection.
  • Minister Muraleedharan stated that a dedicated medical board would be formed to examine the prescribing practices and supply chain integrity.
  • The investigation will also assess whether the expired medication contributed to the high mortality rate observed in the recent outbreak.
  • No official statements from the medical board or the pharmaceutical suppliers have yet been released.
"We will not let such lapses go unchecked. A thorough probe will be conducted to determine if expired drugs were used and to hold those responsible accountable," said K. Muraleedharan.

Background & Context

Remdesivir, an antiviral originally developed for Ebola, has been repurposed for several viral infections, including COVID‑19 and Nipah. The drug is time‑sensitive, with a limited shelf life once reconstituted. In Kerala, a surge of Nipah cases has prompted heightened scrutiny of treatment protocols and drug storage practices.

Impact & Analysis

  • Patient safety: The use of expired medication could compromise treatment efficacy and increase mortality.
  • Regulatory oversight: The probe highlights potential gaps in drug monitoring and enforcement of expiry standards.
  • Public trust: Transparency about the investigation may affect community confidence in the health system.
  • Policy review: The incident may lead to stricter guidelines for drug storage, distribution, and prescription.

What Happens Next

  • A medical board will be constituted within the next week.
  • The board will collect medical records, interview clinicians, and examine drug batches.
  • Preliminary findings are expected by the end of the month.
  • Depending on outcomes, legal or administrative actions could follow against responsible parties.

---

Was this story useful?
Share on WhatsApp